Crossmark

Compound heterozygous variants in <i>OTULIN</i> are associated with fulminant atypical late‐onset ORAS

Crossref DOI link: https://doi.org/10.15252/emmm.202114901

Published Online: 2022-02-16

Published Print: 2022-03-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Zinngrebe, Julia

Moepps, Barbara

Monecke, Thomas

Gierschik, Peter https://orcid.org/0000-0001-9295-5231
Schlichtig, Ferdinand

Barth, Thomas F E

Strauß, Gudrun

Boldrin, Elena

Posovszky, Carsten

Schulz, Ansgar

Beringer, Ortraud

Rieser, Eva

Jacobsen, Eva‐Maria

Lorenz, Myriam Ricarda

Schwarz, Klaus

Pannicke, Ulrich

Walczak, Henning https://orcid.org/0000-0002-6312-4591
Niessing, Dierk https://orcid.org/0000-0002-5589-369X
Schuetz, Catharina

Fischer‐Posovszky, Pamela https://orcid.org/0000-0003-3402-9840
Debatin, Klaus‐Michael
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (SFB1399)

Deutsche Forschungsgemeinschaft (Fi1700/7‐1)

Deutsche Forschungsgemeinschaft (SFB1403‐414786233)

Medical Research Council (MR/S00811X/1)

Cancer Research UK (A17341)

International Graduate School in Molecular Medicine Ulm

Else Kröner-Fresenius-Stiftung
License Information

Version of Record valid from 2022-02-16
More Information

Publication History

Received: 2021-07-26

Accepted: 2022-01-24

Published: 2022-02-16